{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T04:51:32Z","timestamp":1649134292496},"reference-count":18,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2011,2,24]],"date-time":"2011-02-24T00:00:00Z","timestamp":1298505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatric Reports"],"abstract":"<jats:p>Controversial issues on the management of empiric therapy and diagnosis of febrile neutropenia (FN) were faced by a Consensus Group of the Italian Association of Pediatric Hematology-Oncology (AIEOP). In this paper we report the suggestions of the consensus process regarding the role of aminoglycosides, glycopeptides and oral antibiotics in empiric therapy of FN, the rules for changing or discontinuing the therapy as well as the timing of the blood cultures.<\/jats:p>","DOI":"10.4081\/pr.2011.e4","type":"journal-article","created":{"date-parts":[[2011,3,28]],"date-time":"2011-03-28T08:56:23Z","timestamp":1301302583000},"page":"e4","source":"Crossref","is-referenced-by-count":2,"title":["Consensus on Diagnosis and Empiric Antibiotic Therapy of Febrile Neutropenia"],"prefix":"10.3390","volume":"3","author":[{"given":"Nagua","family":"Giurici","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulio","family":"Zanazzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2011,2,24]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1179\/joc.2001.13.3.281","article-title":"Cost effectiveness of cefepime+netilmicin or ceftazidime+amikacin or meropenem monotherapy in febrile neutropenic children with malignancy in Tukey","volume":"13","author":"Agaoglu","year":"2001","journal-title":"J Chemother"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/08880010590896297","article-title":"Cefepime versus ceftazidime+amikacin as empirical therapy for febrile neutropenia inc hildren with cancer: a prospective randomized trial of the treatment efficacy and cost","volume":"22","author":"Corapcioglu","year":"2005","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref3","first-page":"141","article-title":"Cefepime monotherapy is as effective as cetriaxone plus amikacin in pediatric patient with caner and high-risk febrile neutropenia in a randomized comparison","volume":"42","author":"Pereira","year":"2009","journal-title":"J Microbiol Immunol Infect"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"i14","DOI":"10.1093\/jac\/dkp075","article-title":"Why empirical therapy?","volume":"63","author":"Klastersky","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"i16","DOI":"10.1093\/jac\/dkp076","article-title":"Where do we go from here?","volume":"63","author":"Pizzo","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/CCO.0b013e32833a8752","article-title":"Supportive care in children","volume":"22","author":"Santolaya","year":"2010","journal-title":"Curr Opin Oncol"},{"key":"ref7","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003914.pub2","article-title":"Additional anti-Gram-positive antibiotic treatment for febrile neutropenic cancer patients","volume":"CD00 3914","author":"Paul","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S1473-3099(05)70164-X","article-title":"Role of glycopeptides as part of initial treatment of febrile neutropenic patients: a meta analysis of randomized controlled trials","volume":"5","author":"Vardakas","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/jac\/dki028","article-title":"Empirical antibiotics against Gram-positive infections for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials","volume":"55","author":"Paul","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/MPH.0b013e3181acd8cd","article-title":"Randomized control trial comparing oral moxicillin-clavulanate and ofloxacin with intravenous ceftriaxone and amikacina as outpatient therapy in peiatric low-risk febrile neutropenia","volume":"31","author":"Gupta","year":"2009","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref11","first-page":"531","article-title":"Oral vs intravenous empirical antimicrobial therapy in febrile neutropenic patients receiving childhood cancer chemotherapy","volume":"85","author":"Cagol","year":"2009","journal-title":"J Pediatr (Rio J)"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/(SICI)1096-911X(200002)34:2<87::AID-MPO2>3.0.CO;2-F","article-title":"Oral ciprofloxacin vs intravenous ceftriaxone administered in an outpatient setting for fever and neutropenia in low-risk pediatric oncology patients: randomized prospective trial","volume":"34","author":"Petrilli","year":"2000","journal-title":"Med Pediatr Oncol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"v252","DOI":"10.1093\/annonc\/mdq196","article-title":"Management of febrile neutropenia: ESMO Clinical Practice Guidelines","volume":"21","author":"de Naurois","year":"2010","journal-title":"Ann of Oncol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s00520-009-0725-0","article-title":"Utility of peripheral blood cultures in bacteremic pediatric cancer patients with a central lin","volume":"18","author":"Scheinemann","year":"2010","journal-title":"Support Care Cancer"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1128\/JCM.38.6.2181-2185.2000","article-title":"Frequency of low level bacteremia in children from birth to fifteen years of age","volume":"38","author":"Kellogg","year":"2000","journal-title":"J Clin Microbiol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1542\/peds.2006-0440","article-title":"How reliable is a negative blood culture result? Volume of blood submitted for culture in routine practice in a children's hospital","volume":"119","author":"Connell","year":"2007","journal-title":"Pediatric"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1128\/JCM.02033-07","article-title":"Timing of specimen collection for blood cultures from febrile patients with Bacteremia","volume":"46","author":"Riedel","year":"2008","journal-title":"J Clin Microbiol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1093\/annonc\/mdm351","article-title":"Bloodstream infections in neutropenic patients: early detection of pathogen and directed antimicrobial therapy due to surveillance blood cultures","volume":"18","author":"Penack","year":"2007","journal-title":"Ann Oncol"}],"container-title":["Pediatric Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2036-7503\/3\/1\/e4\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T03:13:29Z","timestamp":1644462809000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2036-7503\/3\/1\/e4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,24]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2011,2]]}},"alternative-id":["pr.2011.e4"],"URL":"https:\/\/doi.org\/10.4081\/pr.2011.e4","relation":{},"ISSN":["2036-7503"],"issn-type":[{"value":"2036-7503","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,24]]}}}